Gefitinib (ZD1839) Stops Hepatic Stellate Mobile G..

Creó nuevo artículo

4 años - Traducciones

Gefitinib (ZD1839) Stops Hepatic Stellate Mobile Growth by Controlling Peroxisome Proliferator-Activated Receptor gamma/ Heme oxygenase-1 Expression | #selinexor #niraparib #gefitinib (ZD1839)

Gefitinib (ZD1839) Stops Hepatic Stellate Mobile Growth by Controlling Peroxisome Proliferator-Activated Receptor gamma/

Phosphoinositide-3-kinases (PI3Ks) are essential oncology goals as a result of deregulation with this signaling walkway inside a wide range of human b

Me gusta

Comentario